About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Texas | 723 Studies

Clinical Trials Colorectal CancerTexas

Colorectal Cancer Clinical Trials in Texas

Find 723 clinical trials for colorectal cancer near Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 723 trials

Active not recruitingNational Cancer Institute "Cancer Moonshot Biobank"This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study.NCT04314401·Daphne, Alabama and 149 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedAntibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal CancerThis trial is being performed in two parts: Dose Escalation and Dose Expansion.NCT02991196·Washington D.C., District of Columbia and 3 others

TerminatedRandomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver MetastasesPreliminary studies with a variety of vaccines suggest target accessibility (potential immunogenicity) in a variety of solid tumors to immune directed approaches.NCT01505166·Dallas, Texas

CompletedAssessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer PatientsPrimary Objectives: * To determine the feasibility of a study that would describe changes of certain circulating inflammatory cytokines (interleukin-1, 6, 8, 10, 12, and tumor…NCT00502502·Houston, Texas

CompletedTrial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.This study compares in the first study period combination of Irinotecan with three different methods of administration by Fluoropyrimidine. (ie. infusion, bolus and oral).NCT00101686·Birmgingham, Alabama and 174 others

CompletedStudy of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal CancerThe primary objectives of this study are: (Phase 1b) to investigate the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) for magrolimab in combination…NCT02953782·Los Angeles, California and 7 others

CompletedMulti-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesThe objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer.NCT01260168·Birmingham, Alabama and 20 others

TerminatedAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesThis was a study of INCB054329 given to patients with advanced malignancies that were conducted in three treatment groups.NCT02431260·Los Angeles, California and 11 others

TerminatedCombination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or…NCT00023868·Tucson, Arizona and 8 others

CompletedSafety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2The purpose of this study is to investigate a safe dose of TAK-165, once daily (QD), in patients with HER2-tumor expression.NCT00034281·Scottsdale, Arizona and 3 others

RecruitingStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer…NCT05489211·Los Angeles, California and 95 others

RecruitingA Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsThe purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors that have Human Epidermal…NCT06695845·Prescott, Arizona and 27 others

CompletedPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesThe purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or…NCT03126110·Los Angeles, California and 37 others

UnknownSafety and Efficacy Study of DCVax-Direct in Solid TumorsThe study comprises a Phase I component during which the optimal dose of DCVax-Direct for the treatment of solid tissue tumors will be identified, followed by a Phase II component…NCT01882946·Orlando, Florida and 1 other

Active not recruitingBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsThis trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this…NCT04579380·Phoenix, Arizona and 107 others

CompletedChromogranin A as Blood Marker in Cancer PatientsGastroentero-pancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of neoplasms that arise from enterochromaffin cells of the gastrointestinal (GI) tract and…NCT03817866·Palo Alto, California and 3 others

UnknownStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesStudy of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNCT04913337·Los Angeles, California and 26 others

Active not recruitingDose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)To find the highest and/or recommended dose of TROP2-CAR-NK cells combined with cetuximab in participants with MRD CRC.NCT06358430·Houston, Texas

Active not recruitingCancer Preventive Vaccine Nous-209 for Lynch Syndrome PatientsThis phase Ib/II trial evaluates the safety and effect of the Nous-209 vaccine in Lynch syndrome patients.NCT05078866·Duarte, California and 3 others

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

PreviousPage 18 of 37Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma